IP Library Granted Patent US 9,526,715
Granted Patent B1
US 9,526,715 · App. 15/171,517 · Granted Dec 27, 2016

Chemical engineering processes and apparatus for the synthesis of compounds

Inventors: Robert Winnicki (Cambridge, MA); Marc Donsky (Denver, CO)
Assignee: Full Spectrum Laboratories Limited
A61K31/352C12P7/42C12P17/06C12Y121/03007C12Y121/03008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,526,715
App. No.
15/171,517
Granted
Dec 27, 2016
Kind
B1
Abstract

The present invention provides methods for producing cannabinoids and cannabinoid analogs as well as a system for producing these compounds. The inventive method is directed to contacting a compound according to Formula I or Formula II with a cannabinoid synthase. Also described is a system for producing cannabinoids and cannabinoid analogs by contacting a THCA synthase with a cannabinoid precursor and modifying at least one property of the reaction mixture to influence the quantity formed of a first cannabinoid relative to the quantity formed of a second cannabinoid.

Claims (37)

1. An in vitro method for producing

(a) tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) in different ratios or

(b) cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) in different ratios comprising the steps of:

reacting cannabigerolic acid (CBGA) with a cannabinoid synthase in a reaction mixture;

modifying one or more properties of the reaction mixture to produce

(i) tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) when the cannabinoid synthase is tetrahydrocannabinolic acid synthase (THCA synthase);

or

(ii) cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) when the cannabinoid synthase is cannabidiolic acid synthase (CBDA synthase); and

recovering the tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) or tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) so produced, wherein the different ratios are determined by a pH of the reaction mixture less than 8.0, which allows for the different ratios.

2. The method of claim 1 , wherein the cannabinoid synthase is tetrahydrocannabinolic acid synthase (THCA synthase).

3. The method of claim 2 , wherein the cannabinoid synthase is immobilized on a solid support.

4. The method of claim 1 , wherein the cannabinoid synthase is a recombinant cannabinoid synthase, and the method further comprises producing the recombinant cannabinoid synthase.

5. The method of claim 4 , wherein the step of producing recombinant THCA synthase comprises overexpressing the THCA synthase.

6. The method of claim 5 , wherein the THCA synthase is expressed in yeast or in Escherichia coli.

7. The method of claim 1 , wherein the cannabinoid synthase is CBDA synthase and wherein the method produces CBDA and CBCA in different ratios.

8. The method of claim 1 , wherein the reaction mixture comprises a solvent, which is one or more of dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), iso-propoyl alcohol and cyclodextrin, and wherein the amount of the solvent in the reaction mixture is between 5% and 30% (w/v).

9. The method of claim 8 , wherein the one or more properties of the reaction mixture are the reaction solvent, the ionic strength of the reaction medium, the temperature of the reaction, the reaction pressure, the viscosity of the reaction mixture or the concentration of the reagents.

10. An ex vivo method for producing tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) in different ratios comprising the steps of:

reacting cannabigerolic acid (CBGA) with tetrahydrocannabinolic acid synthase (THCA synthase) in a reaction mixture;

modifying one or more properties of the reaction mixture to produce tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) in different ratios; and

recovering the tetrahydrocannabinolic acid (THCA) and cannabichromenic acid (CBCA) so produced, wherein the different ratios are determined by a pH of the reaction mixture less than 8.0 which allows for the different ratios.

11. The method of claim 10 , wherein the THCA synthase is immobilized on a solid support.

12. The method of claim 10 , wherein the THCA synthase is a recombinant THCA synthase, and the method further comprises producing recombinant THCA synthase.

13. The method of claim 12 , wherein the step of producing recombinant THCA synthase comprises overexpressing the THCA synthase.

14. The method of claim 13 , wherein the THCA synthase is expressed in yeast or in Escherichia coli.

15. The method of claim 10 wherein the reaction mixture comprises a solvent, which is one or more of dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), iso-propoyl alcohol and cyclodextrin, and wherein the amount of the solvent in the reaction mixture is between 5% and 30% (w/v).

16. The method of claim 15 , wherein the one or more properties of the reaction mixture are the reaction solvent, the ionic strength of the reaction medium, the temperature of the reaction, the reaction pressure, the viscosity of the reaction mixture or the concentration of the reagents.

17. The method of claim 15 , wherein the CBDA synthase is a recombinant CBDA synthase, and the method further comprises producing recombinant CBDA synthase.

18. The method of claim 17 , wherein the step of producing recombinant CBDA synthase comprises overexpressing the CBDA synthase.

19. The method of claim 18 , wherein the CBDA synthase is expressed in yeast or in Escherichia coli.

20. An ex vivo method for producing cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) in different ratios comprising the steps of:

reacting cannabigerolic acid (CBGA) with cannabidiolic acid synthase (CBDA synthase) in a reaction mixture;

modifying one or more properties of the reaction mixture to produce cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) in different ratios; and

recovering the cannabidiolic acid (CBDA) and cannabichromenic acid (CBCA) so produced, wherein the different ratios are determined by a pH of the reaction mixture less than 8.0, which allows for the different ratios.

21. The method of claim 20 , wherein the CBDA synthase is immobilized on a solid support.

22. The method of claim 20 , wherein the reaction mixture comprises a solvent, which is one or more of dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), iso-propoyl alcohol and cyclodextrin, and wherein the amount of the solvent in the reaction mixture is between 5% and 30% (w/v).

23. The method of claim 22 , wherein the one or more properties of the reaction mixture are the reaction solvent, the ionic strength of the reaction medium, the temperature of the reaction, the reaction pressure, the viscosity of the reaction mixture or the concentration of the reagents.

Assignments (7)
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0448 →
SECURITY INTEREST Recorded Nov 23, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058194/0474 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058180/0377 →
SECURITY INTEREST Recorded Nov 22, 2021
From: TEEWINOT LIFE SCIENCES CORPORATION; TEEWINOT TECHNOLOGIES LIMITED
To: TUATARA CAPITAL FUND I, L.P.; TUATARA CAPITAL PARALLEL FUND I, L.P.
Reel/Frame 058182/0033 →
SECURITY INTEREST Recorded Aug 24, 2020
From: TEEWINOT TECHNOLOGIES, LTD.
To: TUATARA CAPITAL FUND I, L.P.
Reel/Frame 053582/0897 →
CHANGE OF NAME Recorded Dec 8, 2017
From: FULL SPECTRUM LABORATORIES LIMITED
To: TEEWINOT TECHNOLOGIES LIMITED
Reel/Frame 044804/0125 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2016
From: WINNICKI, ROBERT; DONSKY, MARC
To: FULL SPECTRUM LABORATORIES LIMITED
Reel/Frame 040083/0476 →
Continuity (3)
Continuation 14836339 · Aug 26, 2015
Continuation PCTUS2014018944 · Feb 27, 2014
Provisional Application 61770766 · Feb 28, 2013